Tekla Life Sciences Inves...

NYSE: HQL · Real-Time Price · USD
13.79
-0.26 (-1.85%)
At close: Aug 22, 2025, 3:59 PM
13.83
0.29%
After-hours: Aug 22, 2025, 05:16 PM EDT

Tekla Life Sciences Investors Ratios and Metrics

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
PE Ratio
4.96 15.78 -3.35 7.82
PEG Ratio
0.02 -0.13 0.01 -0.16
PS Ratio
4.88 8.96 11.01 11.21
PB Ratio
0.92 0.88 0.88 0.96
P/FCF Ratio
n/a n/a n/a n/a
P/OCF Ratio
n/a n/a n/a n/a
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a n/a 0.03 0.00
Quick Ratio
0.32 n/a 0.12 0.01
Current Ratio
0.32 n/a 0.12 0.01
Asset Turnover
0.19 0.10 0.08 0.08
Interest Coverage
n/a n/a n/a n/a
Return on Equity
0.19 0.06 -0.26 0.12
Return on Assets
0.19 0.06 -0.25 0.12
Return on Invested Capital
0.18 -0.01 -0.25 0.12
Dividend Yield
0.11 0.10 0.11 0.08
Payout Ratio
0.55 1.62 -0.36 0.64
Gross Profit Margin
1.00 0.46 0.83 0.87
Net Profit Margin
0.98 0.57 -3.28 1.43
Pretax Profit Margin
0.98 0.57 -3.28 1.43
Operating Profit Margin
0.98 -0.13 -3.28 1.43
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.98 0.57 -3.28 1.43